SCHEMBL24718415

SCHEMBL24718415

Cc1ccc(O)c(C(=O)NC2CC(=O)N(Cc3ccccc3C(F)(F)F)C2)c1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ TP53 P04637 1/20 0.49
▸ RIPK1 Q13546 1/20 0.42
▸ KDM4E B2RXH2 3/20 0.40
▸ ATM Q13315 2/20 0.40
▸ NPSR1 Q6W5P4 2/20 0.40
▸ TDP1 Q9NUW8 2/20 0.40
▸ MEN1 O00255 2/20 0.40
▸ KMT2A Q03164 2/20 0.40
▸ P2RX7 Q99572 3/20 0.40
▸ SIRT2 Q8IXJ6 1/20 0.39
▸ SIRT1 Q96EB6 1/20 0.39
▸ P2RX1 P51575 1/20 0.39
▸ TMPRSS4 Q9NRS4 1/20 0.39
▸ P2RY14 Q15391 1/20 0.39
▸ HDAC11 Q96DB2 1/20 0.39
▸ ALDH1A1 P00352 3/20 0.38
▸ GAA P10253 2/20 0.38
▸ SIGMAR1 Q99720 1/20 0.37
▸ LIPG Q9Y5X9 1/20 0.36
▸ RAB9A P51151 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24718838 0.93 TP53 (0.49) TP53RIPK1KDM4EATMNPSR1
SCHEMBL24718431 0.91 P2RX7 (0.42) TP53KDM4EATMNPSR1TDP1
SCHEMBL24719125 0.90 TP53 (0.51) TP53RIPK1KDM4EATMNPSR1
SCHEMBL24718659 0.90 MEN1 (0.46) TP53RIPK1MEN1KMT2AP2RX7
SCHEMBL24718416 0.90 TP53 (0.46) TP53RIPK1MEN1KMT2AP2RX7
SCHEMBL24718241 0.90 TP53 (0.46) TP53RIPK1MEN1KMT2AP2RX7
SCHEMBL24718382 0.90 TP53 (0.46) TP53RIPK1MEN1KMT2AP2RX7
SCHEMBL24718281 0.89 TP53 (0.46) TP53RIPK1MEN1KMT2AP2RX7
SCHEMBL24718834 0.89 TP53 (0.46) TP53RIPK1KDM4EATMNPSR1
SCHEMBL24718840 0.89 TP53 (0.45) TP53RIPK1MEN1KMT2AP2RX7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220363633-A1 SUBSTITUTED PYRROLIDONES AND PIPERIDONES AS SMALL MOLECULE INHIBITORS OF EZH2 AND EED PROTEIN BINDING UNITED STATES GOVERNMENT 2022-11-17 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220363633-A1 SUBSTITUTED PYRROLIDONES AND PIPERIDONES AS SMALL MOLECULE INHIBITORS OF EZH2 AND EED PROTEIN BINDING EED, EZH2, ELP1 TP53 284/4885RIPK1 1371/4885KDM4E 37/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback